Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Long-term cognitive function change among breast cancer survivors.

Zheng Y, Luo J, Bao P, Cai H, Hong Z, Ding D, Jackson JC, Shu XO, Dai Q.

Breast Cancer Res Treat. 2014 Aug;146(3):599-609. doi: 10.1007/s10549-014-3044-1. Epub 2014 Jul 9.

2.

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.

Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA.

J Clin Exp Neuropsychol. 2004 Oct;26(7):955-69.

PMID:
15742545
3.

Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors.

Kesler S, Hadi Hosseini SM, Heckler C, Janelsins M, Palesh O, Mustian K, Morrow G.

Clin Breast Cancer. 2013 Aug;13(4):299-306. doi: 10.1016/j.clbc.2013.02.004. Epub 2013 May 4.

4.

Learning and memory performance in breast cancer survivors 2 to 6 years post-treatment: the role of encoding versus forgetting.

Root JC, Andreotti C, Tsu L, Ellmore TM, Ahles TA.

J Cancer Surviv. 2016 Jun;10(3):593-9. doi: 10.1007/s11764-015-0505-4. Epub 2015 Dec 12.

5.
6.

Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.

Jim HS, Phillips KM, Chait S, Faul LA, Popa MA, Lee YH, Hussin MG, Jacobsen PB, Small BJ.

J Clin Oncol. 2012 Oct 10;30(29):3578-87. doi: 10.1200/JCO.2011.39.5640. Epub 2012 Aug 27. Review.

7.

Aging, obesity, and post-therapy cognitive recovery in breast cancer survivors.

Huang Z, Zheng Y, Bao P, Cai H, Hong Z, Ding D, Jackson J, Shu XO, Dai Q.

Oncotarget. 2017 Feb 14;8(7):12364-12373. doi: 10.18632/oncotarget.12565.

9.

Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.

Prokasheva S, Faran Y, Cwikel J, Geffen DB.

J Psychosoc Oncol. 2011;29(5):499-514. doi: 10.1080/07347332.2011.600751.

PMID:
21882931
10.

Impact of increasing physical activity on cognitive functioning in breast cancer survivors: Rationale and study design of Memory & Motion.

Hartman SJ, Natarajan L, Palmer BW, Parker B, Patterson RE, Sears DD.

Contemp Clin Trials. 2015 Nov;45(Pt B):371-376. doi: 10.1016/j.cct.2015.09.021. Epub 2015 Sep 30.

11.

Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?

Ganz PA, Bower JE, Kwan L, Castellon SA, Silverman DH, Geist C, Breen EC, Irwin MR, Cole SW.

Brain Behav Immun. 2013 Mar;30 Suppl:S99-108. doi: 10.1016/j.bbi.2012.07.015. Epub 2012 Aug 3.

12.

Cognitive-behavioral management of chemotherapy-related cognitive change.

Ferguson RJ, Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Mott LA.

Psychooncology. 2007 Aug;16(8):772-7.

13.

Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.

Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB.

J Clin Oncol. 2012 Apr 1;30(10):1080-6. doi: 10.1200/JCO.2011.37.0189. Epub 2012 Feb 27.

PMID:
22370315
14.

Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.

Breckenridge LM, Bruns GL, Todd BL, Feuerstein M.

Psychooncology. 2012 Jan;21(1):43-53. doi: 10.1002/pon.1860. Epub 2010 Oct 21.

PMID:
20967847
15.

Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern.

Schmidt ME, Chang-Claude J, Vrieling A, Heinz J, Flesch-Janys D, Steindorf K.

J Cancer Surviv. 2012 Mar;6(1):11-9. doi: 10.1007/s11764-011-0197-3. Epub 2011 Dec 11.

PMID:
22160661
16.

Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.

Quesnel C, Savard J, Ivers H.

Breast Cancer Res Treat. 2009 Jul;116(1):113-23. doi: 10.1007/s10549-008-0114-2. Epub 2008 Jul 16. Erratum in: Breast Cancer Res Treat. 2009 Jul;116(1):129-30.

PMID:
18629633
17.

Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy.

Yamada TH, Denburg NL, Beglinger LJ, Schultz SK.

J Neuropsychiatry Clin Neurosci. 2010 Winter;22(1):48-54. doi: 10.1176/appi.neuropsych.22.1.48.

18.

Brief self-report measure of work-related cognitive limitations in breast cancer survivors.

Ottati A, Feuerstein M.

J Cancer Surviv. 2013 Jun;7(2):262-73. doi: 10.1007/s11764-013-0275-9. Epub 2013 Apr 4.

PMID:
23552976
19.

Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions.

Nguyen CM, Yamada TH, Beglinger LJ, Cavanaugh JE, Denburg NL, Schultz SK.

Psychooncology. 2013 Apr;22(4):862-8. doi: 10.1002/pon.3086. Epub 2012 May 14.

20.

Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls.

Phillips KM, Jim HS, Small BJ, Laronga C, Andrykowski MA, Jacobsen PB.

Cancer. 2012 Apr 1;118(7):1925-32. doi: 10.1002/cncr.26432. Epub 2011 Dec 12.

Supplemental Content

Support Center